| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.003 | 1 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.0037 | 1 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |